BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 31822569)

  • 1. Sickle cell disease: at the crossroads of pulmonary hypertension and diastolic heart failure.
    Wood KC; Gladwin MT; Straub AC
    Heart; 2020 Apr; 106(8):562-568. PubMed ID: 31822569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of left ventricular diastolic function profile in patients with pulmonary hypertension due to heart failure with preserved ejection fraction.
    Raeisi-Giglou P; Lam L; Tamarappoo BK; Newman J; Dweik RA; Tonelli AR
    Clin Cardiol; 2017 Jun; 40(6):356-363. PubMed ID: 28026030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Hemodynamic Markers of Pulmonary Hypertension and Outcomes in Heart Failure With Preserved Ejection Fraction.
    Vanderpool RR; Saul M; Nouraie M; Gladwin MT; Simon MA
    JAMA Cardiol; 2018 Apr; 3(4):298-306. PubMed ID: 29541759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffuse right ventricular fibrosis in heart failure with preserved ejection fraction and pulmonary hypertension.
    Patel RB; Li E; Benefield BC; Swat SA; Polsinelli VB; Carr JC; Shah SJ; Markl M; Collins JD; Freed BH
    ESC Heart Fail; 2020 Feb; 7(1):253-263. PubMed ID: 31903694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary Hypertension in the Context of Heart Failure With Preserved Ejection Fraction.
    Inampudi C; Silverman D; Simon MA; Leary PJ; Sharma K; Houston BA; Vachiéry JL; Haddad F; Tedford RJ
    Chest; 2021 Dec; 160(6):2232-2246. PubMed ID: 34391755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary hypertension is related to peripheral endothelial dysfunction in heart failure with preserved ejection fraction.
    Farrero M; Blanco I; Batlle M; Santiago E; Cardona M; Vidal B; Castel MA; Sitges M; Barbera JA; Perez-Villa F
    Circ Heart Fail; 2014 Sep; 7(5):791-8. PubMed ID: 25047042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary hypertension with a precapillary component in heart failure with preserved ejection fraction.
    Sera F; Ohtani T; Tamaki S; Yano M; Hayashi T; Nakagawa A; Nakagawa Y; Nakatani D; Yamada T; Yasumura Y; Hikoso S; Yamauchi-Takihara K; Sakata Y;
    Heart; 2023 Mar; 109(8):626-633. PubMed ID: 36543519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary vascular disease in the setting of heart failure with preserved ejection fraction.
    Levine AR; Simon MA; Gladwin MT
    Trends Cardiovasc Med; 2019 May; 29(4):207-217. PubMed ID: 30177249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a Mouse Model of Metabolic Syndrome, Pulmonary Hypertension, and Heart Failure with Preserved Ejection Fraction.
    Meng Q; Lai YC; Kelly NJ; Bueno M; Baust JJ; Bachman TN; Goncharov D; Vanderpool RR; Radder JE; Hu J; Goncharova E; Morris AM; Mora AL; Shapiro SD; Gladwin MT
    Am J Respir Cell Mol Biol; 2017 Apr; 56(4):497-505. PubMed ID: 28118022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Echocardiographic Features of Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction.
    Shah AM; Cikes M; Prasad N; Li G; Getchevski S; Claggett B; Rizkala A; Lukashevich I; O'Meara E; Ryan JJ; Shah SJ; Mullens W; Zile MR; Lam CSP; McMurray JJV; Solomon SD;
    J Am Coll Cardiol; 2019 Dec; 74(23):2858-2873. PubMed ID: 31806129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic Phenotyping of Pulmonary Hypertension in Left Heart Failure.
    Naeije R; Gerges M; Vachiery JL; Caravita S; Gerges C; Lang IM
    Circ Heart Fail; 2017 Sep; 10(9):. PubMed ID: 28912263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into the pulmonary vascular complications of heart failure with preserved ejection fraction.
    Lai YC; Wang L; Gladwin MT
    J Physiol; 2019 Feb; 597(4):1143-1156. PubMed ID: 30549058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ventricular-Arterial Coupling and Exercise-Induced Pulmonary Hypertension During Low-Level Exercise in Heart Failure With Preserved or Reduced Ejection Fraction.
    Obokata M; Nagata Y; Kado Y; Kurabayashi M; Otsuji Y; Takeuchi M
    J Card Fail; 2017 Mar; 23(3):216-220. PubMed ID: 27737768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
    Paulus WJ; Tschöpe C
    J Am Coll Cardiol; 2013 Jul; 62(4):263-71. PubMed ID: 23684677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary Effective Arterial Elastance as a Measure of Right Ventricular Afterload and Its Prognostic Value in Pulmonary Hypertension Due to Left Heart Disease.
    Tampakakis E; Shah SJ; Borlaug BA; Leary PJ; Patel HH; Miller WL; Kelemen BW; Houston BA; Kolb TM; Damico R; Mathai SC; Kasper EK; Hassoun PM; Kass DA; Tedford RJ
    Circ Heart Fail; 2018 Apr; 11(4):e004436. PubMed ID: 29643065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary hemodynamics in heart failure patients with reduced or preserved ejection fraction and pulmonary hypertension: Similarities and disparities.
    Adir Y; Guazzi M; Offer A; Temporelli PL; Cannito A; Ghio S
    Am Heart J; 2017 Oct; 192():120-127. PubMed ID: 28938958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potential of phosphodiesterase type 5 inhibitors in heart failure with preserved ejection fraction and combined post- and pre-capillary pulmonary hypertension.
    Kramer T; Dumitrescu D; Gerhardt F; Orlova K; Ten Freyhaus H; Hellmich M; Baldus S; Rosenkranz S
    Int J Cardiol; 2019 May; 283():152-158. PubMed ID: 30777406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Right ventricular dysfunction in left-sided heart failure with preserved versus reduced ejection fraction.
    Bosch L; Lam CSP; Gong L; Chan SP; Sim D; Yeo D; Jaufeerally F; Leong KTG; Ong HY; Ng TP; Richards AM; Arslan F; Ling LH
    Eur J Heart Fail; 2017 Dec; 19(12):1664-1671. PubMed ID: 28597497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Clinical and Echocardiographic Score to Identify Pulmonary Hypertension Due to HFpEF.
    Berthelot E; Montani D; Algalarrondo V; Dreyfuss C; Rifai R; Benmalek A; Jais X; Bouchachi A; Savale L; Simonneau G; Chemla D; Humbert M; Sitbon O; Assayag P
    J Card Fail; 2017 Jan; 23(1):29-35. PubMed ID: 27742455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel insights into the pathobiology of pulmonary hypertension in heart failure with preserved ejection fraction.
    Aradhyula V; Vyas R; Dube P; Haller ST; Gupta R; Maddipati KR; Kennedy DJ; Khouri SJ
    Am J Physiol Heart Circ Physiol; 2024 Jun; 326(6):H1498-H1514. PubMed ID: 38639739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.